Generic-Drug Cos. Urge Senate To Fight FDA Approval Delays
If the U.S. Senate wants to effectively combat price spikes in off-patent drugs and improve competition within the pharmaceutical market, it needs to prevent delays in the generic approval process, in...To view the full article, register now.
Already a subscriber? Click here to view full article